Nanomaterials for antiangiogenic therapies for cancer: a promising tool for personalized medicine

HO Alsaab, AS Al-Hibs, R Alzhrani… - International journal of …, 2021 - mdpi.com
Angiogenesis is one of the hallmarks of cancer. Several studies have shown that vascular
endothelium growth factor (VEGF) plays a leading role in angiogenesis progression …

Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious …

K Appiah-Kubi, Y Wang, H Qian, M Wu, X Yao, Y Wu… - Tumor Biology, 2016 - Springer
Progress in cancer biology has led to an increasing discovery of oncogenic alterations of the
platelet-derived growth factor receptors (PDGFRs) in cancers. In addition, their …

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo …

M Moehler, I Gepfner-Tuma, A Maderer… - BMC cancer, 2016 - Springer
Background As a multi-targeted anti-angiogenic receptor tyrosine kinase (RTK) inhibitor
sunitinib (SUN) has been established for renal cancer and gastrointestinal stromal tumors. In …

Combining multikinase tyrosine kinase inhibitors targeting the vascular endothelial growth factor and cluster of differentiation 47 signaling pathways is predicted to …

Y Zhang, AS Popel, H Bazzazi - ACS Pharmacology & …, 2023 - ACS Publications
Angiogenesis is a critical step in tumor growth, development, and invasion. Nascent tumor
cells secrete vascular endothelial growth factor (VEGF) that significantly remodels the tumor …

Kidney-targeted irradiation triggers renal ischemic preconditioning in mice

B Khbouz, F Lallemand, A Cirillo… - American Journal …, 2022 - journals.physiology.org
Renal ischemia-reperfusion (I/R) causes acute kidney injury (AKI). Ischemic preconditioning
(IPC) attenuates I/R-associated AKI. Whole body irradiation induces renal IPC in mice. Still …

Peptide inhibitors of vascular endothelial growth factor A: current situation and perspectives

I Guryanov, T Tennikova, A Urtti - Pharmaceutics, 2021 - mdpi.com
Vascular endothelial growth factors (VEGFs) are the family of extracellular signaling proteins
involved in the processes of angiogenesis. VEGFA overexpression and altered regulation of …

[HTML][HTML] Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer

KA Norton, AS Popel, NB Pandey - American journal of cancer …, 2015 - ncbi.nlm.nih.gov
Introduction: Tumor heterogeneity is a well-established concept in cancer research. In this
paper, we examine an additional type of tumor cell heterogeneity-tumor cell-surface receptor …

[HTML][HTML] Quantification of surface-localized and total oxytocin receptor in myometrial smooth muscle cells

Y Fang, EL Reinl, A Liu, TD Prochaska, M Malik… - Heliyon, 2024 - cell.com
Oxytocin acts through the oxytocin receptor (OXTR) to modulate uterine contractility. We
previously identified OXTR genetic variants and showed that, in HEK293T cells, two of the …

[HTML][HTML] M2b macrophages protect against myocardial remodeling after ischemia/reperfusion injury by regulating kinase activation of platelet-derived growth factor …

Y Yue, S Huang, H Li, W Li, J Hou, L Luo… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Myocardial injury is a major cause of myocardial remodeling. Macrophages are
important in cardiac repair as a result of their interactions with fibroblasts. As regulatory …

Dual inhibition of topoisomerase II and tyrosine kinases by the novel bis-fluoroquinolone chalcone-like derivative HMNE3 in human pancreatic cancer cells

YC Ma, ZX Wang, SJ **, YX Zhang, GQ Hu, DT Cui… - PloS one, 2016 - journals.plos.org
Both tyrosine kinase and topoisomerase II (TopII) are important anticancer targets, and their
respective inhibitors are widely used in cancer therapy. However, some combinations of …